---
$id: https://graph.org.ai/products/commodity/51283106
$type: Product
source: UNSPSC
code: "51283106"
title: "Polymyxin b"
class: "51283100"
classTitle: "Lipopeptides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Polymyxin b

**UNSPSC Code**: 51283106
**Class**: [Lipopeptides](Lipopeptides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a polymyxin antibiotic with the molecular formula C55H95N16O13R, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J2VZ07J96K, more generally known as polymyxin b. European Medicines Agency schedules polymyxin b in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03937MIG. The term POLYMYXIN B is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 13, no. 12, 1959, list 3. Most nations schedule polymyxin b under HS 29419000 and SITC 54139. As of Q4 2014, POLYMYXIN B remains the US FDA Preferred Term for this commodity. Polymyxin b bears US NLM identifiers UMLS ID C0032535 and NCI Concept Code C61894. SMILES: CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.

